title: Subcutaneous injection of the HIV-1 fusion inhibitor enfuvirtide (FUZEON) may result in soft-tissue accumulation of Tc-99m MDP.
authors.affiliation: Division of Nuclear Medicine, Department of Radiology, New Jersey Medical School-UMDNJ, NJ, USA.
authors.forename: L E
authors.initials: LE
authors.lastname: Pack
authors.forename: Lionel S
authors.initials: LS
authors.lastname: Zuckier
mesh_terms: D000293:Adolescent; D016477:Artifacts; D003238:Connective Tissue / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000378:metabolism*; D000077560:Enfuvirtide; D005260:Female; D015700:HIV Envelope Protein gp41 / Q000008:administration & dosage*; D023581:HIV Fusion Inhibitors / Q000008:administration & dosage; D006801:Humans; D007279:Injections, Subcutaneous; D010446:Peptide Fragments / Q000008:administration & dosage*; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D013669:Technetium Tc 99m Medronate / Q000493:pharmacokinetics*
chemical_list: D015700:HIV Envelope Protein gp41; D023581:HIV Fusion Inhibitors; D010446:Peptide Fragments; D019275:Radiopharmaceuticals; D000077560:Enfuvirtide; D013669:Technetium Tc 99m Medronate